Pulmonary fibrosis: When the lungs lose their ability to breathe

Health · Published 3 October 2026 Swipe more like this →

In short: Pulmonary fibrosis is a progressive disease where lung tissue becomes scarred and stiff, making it increasingly difficult for oxygen to enter the bloodstream. While the condition is irreversible, early diagnosis and targeted therapies can help manage symptoms and slow the decline of lung function for those affected.

Pulmonary fibrosis involves the thickening and scarring of tissue surrounding the alveoli, the tiny air sacs responsible for gas exchange. This structural change reduces the lungs' compliance, turning them stiff and inefficient. As the disease advances, patients typically experience a persistent dry cough, unintended weight loss, extreme fatigue, and progressive shortness of breath. A hallmark physical sign is clubbing, where the tips of the fingers or toes become rounded and widened.

The origins of this scarring are diverse. Known triggers include long-term exposure to environmental pollutants like silica, asbestos, or coal dust, as well as side effects from radiation therapy or specific medications, such as chemotherapy drugs and certain heart treatments. Additionally, systemic conditions like rheumatoid arthritis, lupus, and scleroderma can cause secondary lung damage. However, in many cases, no definitive cause is identified. When the source remains elusive, the condition is classified as idiopathic pulmonary fibrosis (IPF), which predominantly affects middle-aged and older adults.

There is currently no cure for pulmonary fibrosis, and the rate of progression varies significantly between individuals. Some patients remain stable for years, while others experience rapid deterioration. Acute exacerbations—sudden, life-threatening worsenings of breathlessness—can occur with little warning. Management focuses on supportive care, including oxygen therapy to improve activity levels and pulmonary rehabilitation to strengthen breathing mechanics. For those who qualify, lung transplantation remains a potential, albeit rare, intervention.

Modern treatment strategies also include antifibrotic medications like nintedanib and pirfenidone, which are designed to slow the rate of scarring. Because the disease compromises the body's ability to fight infection, patients are often advised to maintain rigorous hygiene and stay current on vaccinations for influenza, pneumonia, and RSV. Ongoing research continues to investigate the underlying mechanisms of aberrant wound healing, aiming to provide better outcomes for those living with this restrictive lung disease.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

• The progressive scarring of the lungs that steals breath from the body
• Why does the lung turn to stone, and why is the cause still unknown?
• When the lungs turn to stone: understanding the biology of interstitial lung disease
• The silent scarring of the lungs: understanding Interstitial Lung Disease
• Asbestosis is a silent, decades-long lung injury caused by microscopic mineral fibers.
• Pulmonology began with rediscovering lung circulation
• Fluid in the lungs is usually a heart problem wearing a disguise
• Your pulse is an artery answering each heartbeat
• When food or liquid goes down the wrong pipe, what actually happens inside?
• Can an algorithm teach us to make better life choices through trial and error?
• Public health works on populations, not just patients
• Quackery sells false cures and steals real chances

More in Health, medicine and disease · More in Health · Latest · A–Z · All topics